|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/28 | (2006.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61P 25/28 | (2006.01) |
| (11) | Number of the document | 3747464 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20176370.3 |
| Date of filing the European patent application | 2009-09-16 | |
| (97) | Date of publication of the European application | 2020-12-09 |
| (45) | Date of publication and mention of the grant of the patent | 2024-06-26 |
| (46) | Date of publication of the claims translation | 2024-08-26 |
| (30) | Number | Date | Country code |
| 97464 P | 2008-09-16 | US |
| (72) |
Smith, Craig , US
Chin, Peter S. , US
|
| (73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Progresuojančios išsėtinės sklerozės gydymo būdai, naudojant anti- CD20 antikūnus |
| METHODS FOR TREATING PROGRESSIVE MULTIPLE SCLEROSIS USING AN ANTI-CD20 ANTIBODY |
| Payment date | Validity (years) | Amount | |
| 2025-08-20 | 17 | 347.00 EUR |
| 2026-09-16 |